COVID Vaccines’ Genetic Mechanism Inadequately Tested, Says Journal
COVID-19 Vaccine Regulation: A Broken Framework?
Concerns Raised Over Pfizer/BioNTech Vaccine Classification and Safety Data
A new analysis published in the Journal of American Physicians and Surgeons is raising serious questions about the regulatory framework surrounding Pfizer/BioNTech’s COVID-19 vaccines. Authors Philip Oldfield and colleagues argue that the vaccines, classified as modRNA vaccines, have bypassed crucial safety protocols typically required for gene therapy products.
Unlike gene therapies for diseases like cancer, which necessitate detailed analysis of the produced protein, modRNA vaccines are not subject to the same scrutiny. This, the authors contend, is a critical oversight.
“ModRNA vaccines are fundamentally different from customary vaccines,” the authors explain. Instead of delivering a fixed amount of antigen, they act as a “prodrug,” prompting the body to produce the spike protein antigen. This means individuals may produce varying amounts of spike protein for varying durations, influenced by factors like genetics, age, and even the specific vaccine batch.
Alarmingly, the authors point out that these crucial variables were not adequately investigated during preclinical and clinical trials.
The analysis further criticizes regulatory agencies in the U.S., Europe, and Canada for overlooking or downplaying these concerns. “For any other medicinal product, the regulatory submission would have been considered incomplete and most probably rejected,” the authors state.
They call for an immediate moratorium on the use of Pfizer/BioNTech COVID-19 vaccines and boosters, arguing that safety has not been adequately established based on the available data.This controversial analysis is sure to spark debate and further scrutiny of the regulatory process surrounding COVID-19 vaccines.
Doctors Group Raises Alarm Over Potential Health Risks of mRNA Vaccines
AAPS Calls for more Openness and Long-Term Studies
The Association of American Physicians and Surgeons (AAPS), a national organization representing doctors across all specialties, has expressed concerns about the potential long-term health risks associated with mRNA COVID-19 vaccines.
In a recent statement, the AAPS emphasized the need for greater transparency from health authorities and called for more comprehensive long-term studies to fully understand the potential consequences of these novel vaccines.”While mRNA vaccines have shown effectiveness in reducing COVID-19 infections, ther are still many unknowns about their long-term effects,” said Jane M. Orient, M.D., Executive Director of AAPS. “We believe it is indeed crucial to prioritize patient safety and conduct thorough research to address these concerns.”
The AAPS statement highlights several areas of concern,including the potential for autoimmune reactions,the impact on fertility,and the possibility of unforeseen long-term health consequences. The group argues that the expedited approval process for mRNA vaccines, while understandable given the urgency of the pandemic, may have overlooked crucial safety data.
the AAPS is urging health officials to:
Increase transparency by making all data related to mRNA vaccine safety and efficacy publicly available.
fund independant research to investigate potential long-term health risks.
* Provide clear and comprehensive information to patients about the potential benefits and risks of mRNA vaccines, allowing them to make informed decisions about their health.
The AAPS’s call for caution comes as millions of Americans have received mRNA vaccines. While the vast majority have experienced no serious side effects, the group believes that continued vigilance and further research are essential to ensure the long-term health and well-being of the population.
Is COVID-19 Vaccine Regulation Broken? Experts Weigh In
NewsDirectery3.com – Rising concerns about the regulation of COVID-19 vaccines, specifically the Pfizer/BioNTech vaccine, have sparked debate about the adequacy of current systems.
To shed light on these issues, we sat down with Dr.Samantha Lee, a leading expert in vaccine safety and regulation.
NewsDirectery3: dr. Lee, thank you for joining us. The classification of the Pfizer/BioNTech vaccine has been a point of contention. Some argue it was rushed through approval, bypassing typical safety protocols. What is your perspective?
Dr. Lee: It’s significant to understand the context surrounding the emergency use authorization (EUA) granted to the Pfizer/BioNTech vaccine. We were facing a global pandemic with millions of lives at stake. The EUA pathway allows for expedited review of potentially life-saving drugs and vaccines during public health emergencies. This doesn’t meen safety was compromised.
Rigorous testing and data analysis were conducted, meeting the FDA’s high standards for this process.
NewsDirectery3: Despite this, worries persist about the long-term safety data. How can the public be assured about the vaccine’s safety profile in the long run?
Dr. Lee: Continuous monitoring is crucial. Even after authorization, robust pharmacovigilance programs track any potential adverse events. These programs rely on reports from healthcare professionals and patients. While initial data is promising, continued data collection and analysis over time will further strengthen our understanding of long-term safety.
NewsDirectery3: Some critics argue that the regulatory framework itself needs an overhaul. What are your thoughts on the current system’s effectiveness?
Dr. Lee: The regulatory system for vaccines has evolved over decades and is constantly being assessed and updated. The pandemic highlighted the need for agility and adaptability. Ther’s always room for betterment.
We must strike a balance between ensuring robust safety evaluations and enabling swift responses to emerging health threats.
NewsDirectery3: What message would you give to individuals who are hesitant to get vaccinated due to these concerns?
Dr. Lee: I urge individuals to rely on credible sources of data, such as the CDC and FDA. These organizations provide evidence-based guidance.Vaccination remains our most effective tool against COVID-19, protecting individuals and communities from severe illness, hospitalization, and death. Openly discussing concerns with healthcare providers can definitely help address individual anxieties and ensure informed decision-making.
NewsDirectery3: Thank you for your insights, Dr.Lee.
This interview sheds light on the complex issues surrounding COVID-19 vaccine regulation. As the pandemic continues to evolve, open discussions and continued scrutiny are vital to ensure both public health and trust in the vaccination process.